Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M69,029Revenue $M8,264Net Margin (%)11.2Z-Score2.7
Enterprise Value $M82,079EPS $2.7Operating Margin %24.8F-Score6
P/E(ttm))85.2Cash Flow Per Share $4.9Pre-tax Margin (%)13.4Higher ROA y-yY
Price/Book14.010-y EBITDA Growth Rate %10.5Quick Ratio1.2Cash flow > EarningsY
Price/Sales8.55-y EBITDA Growth Rate %55.9Current Ratio1.5Lower Leverage y-yY
Price/Cash Flow11.8y-y EBITDA Growth Rate %148ROA % (ttm)3.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)3ROE % (ttm)18.1Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M336ROI % (ttm)-4.0Gross Margin Increase y-yY

Gurus Latest Trades with VRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRXGlenn Greenberg 2014-12-31 Reduce-2.23%$113.56 - $146.39
($134.66)
$ 205.3234%Reduce -6.98%6,126,609
VRXSteve Mandel 2014-12-31 Reduce-1.39%$113.56 - $146.39
($134.66)
$ 205.3234%Reduce -24.90%8,250,886
VRXWallace Weitz 2014-12-31 Reduce-1.2%$113.56 - $146.39
($134.41)
$ 205.3235%Reduce -18.50%1,378,606
VRXJoel Greenblatt 2014-12-31 Buy 0.34%$113.56 - $146.39
($134.66)
$ 205.3234%New holding295,632
VRXRuane Cunniff 2014-12-31 Reduce-0.11%$113.56 - $146.39
($134.66)
$ 205.3234%Reduce -0.47%34,331,973
VRXLou Simpson 2014-12-31 Reduce-0.11%$113.56 - $146.39
($134.66)
$ 205.3234%Reduce -1.19%1,794,227
VRXGlenn Greenberg 2014-09-30 Add2.6%$106.73 - $130.26
($118.9)
$ 205.3242%Add 8.86%6,586,582
VRXLou Simpson 2014-09-30 Add1.01%$106.73 - $130.26
($118.9)
$ 205.3242%Add 12.40%1,815,916
VRXWallace Weitz 2014-09-30 Add0.54%$106.73 - $130.26
($118.9)
$ 205.3242%Add 9.05%1,691,525
VRXSteve Mandel 2014-09-30 Add0.46%$106.73 - $130.26
($118.9)
$ 205.3242%Add 8.89%10,985,940
VRXGeorge Soros 2014-09-30 Add0.15%$106.73 - $130.26
($118.9)
$ 205.3242%Add 32.73%626,748
VRXChris Davis 2014-09-30 Add0.15%$106.73 - $130.26
($118.9)
$ 205.3242%Add 11.91%3,529,237
VRXRuane Cunniff 2014-09-30 Add0.14%$106.73 - $130.26
($118.9)
$ 205.3242%Add 0.57%34,494,015
VRXJoel Greenblatt 2014-09-30 Sold Out -0.01%$106.73 - $130.26
($118.9)
$ 205.3242%Sold Out0
VRXGlenn Greenberg 2014-06-30 Add2.33%$116.99 - $138.13
($127.6)
$ 205.3238%Add 8.19%6,050,442
VRXSteve Mandel 2014-06-30 Add0.64%$116.99 - $138.13
($127.6)
$ 205.3238%Add 14.44%10,089,450
VRXJohn Paulson 2014-06-30 Reduce-0.32%$116.99 - $138.13
($127.6)
$ 205.3238%Reduce -49.97%500,300
VRXGeorge Soros 2014-06-30 Add0.29%$116.99 - $138.13
($127.6)
$ 205.3238%Add 185.46%472,187
VRXWallace Weitz 2014-06-30 Reduce-0.19%$116.99 - $138.13
($127.6)
$ 205.3238%Reduce -2.91%1,551,076
VRXChris Davis 2014-06-30 Add0.17%$116.99 - $138.13
($127.6)
$ 205.3238%Add 16.03%3,153,748
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


VRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Chai-Onn Robert RoswellEVP, CLO, General Counsel 2015-03-02Sell90,939$200.014.72view
Farmer Ronald HaroldDirector 2014-12-12Buy500$160.4830.52view
UBBEN JEFFREY W 2014-12-10Buy250,000$140.0649.55view
Stevenson, Katharine BerghuisDirector 2014-12-03Buy1,500$145.7343.73view
STEVENSON KATHARINE BERGHUISDirector 2014-12-03Buy1,500$145.7343.73view
Farmer Ronald HaroldDirector 2014-11-24Buy1,000$163.9527.76view
Farmer, RonDirector 2014-11-24Buy1,000$163.9527.76view
UBBEN JEFFREY W 2014-11-24Buy210,000$142.2547.25view
Chai-Onn, Robert RoswellSenior Officer 2014-06-23Sell10,203$121.772.11view
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy. 2014-06-23Sell10,203$121.772.11view

Press Releases about VRX :

    Quarterly/Annual Reports about VRX:

    News about VRX:

    Articles On GuruFocus.com
    The Top Guru-Held Canadian Stocks Apr 11 2015 
    Valeant Finally Bags Salix for $11 Billion Apr 06 2015 
    Pershing Square Holdings: First Annual Report Mar 25 2015 
    This Week’s Pharma Highlights Mar 19 2015 
    Valeant Pharmaceuticals Goes Aggressive To Win Over Salix Mar 18 2015 
    Valeant Pharma Acquires Salix Mar 18 2015 
    Ruane, Cunniff & Goldfarb Inc Comments on Valeant Mar 16 2015 
    Ruane, Cunniff & Goldfarb’s Sequoia Fund Q4 2014 Shareholder Letter Mar 16 2015 
    Ruane Cunniff Sells Portions of Five of its Top 10 Stakes Mar 13 2015 
    Valeant Pharmaceuticals Finally Zeros In On Salix Pharmaceuticals Feb 24 2015 


    More From Other Websites
    Autohome, Other Foreign Stock Leaders Seen Posting Big Q1 Apr 13 2015
    Pacira Announces Encouraging Data on Lead Drug Exparel - Analyst Blog Apr 13 2015
    eBay Inc (EBAY), Yahoo! Inc. (YHOO), Valeant Pharmaceuticals (VRX): Ivory Capital Continues to... Apr 13 2015
    Why Mylan, Teva and Perrigo are This Year's Valeant, Allergan and Actavis Apr 13 2015
    Activist Jeffrey Ubben’s Picks Blow Away S&P 500 Index in Q1 Apr 12 2015
    The Top Guru-Held Canadian Stocks Apr 11 2015
    Shire's SHP625 Fails in Phase II, FDA Accepts Lifitegrast NDA - Analyst Blog Apr 10 2015
    Valeant VP’s $50.6 Million Pay Second to Apple Among Non-CEOs Apr 10 2015
    Tiger Ratan Trumps Hedge Fund Industry in Q1; See How Nehal Chopra’s Stock Picks Performed Apr 10 2015
    Analysts' Actions -- Cabela's, Weatherford, Whiting Petroleum and More Apr 10 2015
    Specialty pharma; remember those two words: Cramer Apr 09 2015
    Allergan drops lawsuit againt Valeant and Pershing Square Apr 09 2015
    Should Mylan Marry Perrigo Or Teva? Street Debates Apr 09 2015
    Roche's Avastin's Label Expanded in EU for Cervical Cancer - Analyst Blog Apr 09 2015
    Billionaire Paulson's Merger Hedge Fund Gains 10% in 2015 Apr 09 2015
    Valeant Pharmaceuticals Intl Inc (VRX), Ctrip.com International, Ltd. (ADR) (CTRP): Hound... Apr 09 2015
    Allergan, Valeant and Ackman End Legal Battle Over Failed Buyout Apr 09 2015
    Allergan, Valeant, Pershing Square Settle Lawsuits Apr 09 2015
    Mylan Proposes to Acquire Perrigo, Sets Both Stocks Soaring - Analyst Blog Apr 09 2015
    Billionaire Halvorsen’s Picks Dominated S&P 500 Index in Q1: Alibaba Group Holding Ltd (BABA),... Apr 09 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK